<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28806773</article-id><article-id pub-id-type="pmc">5564164</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0182888</article-id><article-id pub-id-type="publisher-id">PONE-D-16-25664</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Imaging Techniques</subject><subj-group><subject>Neuroimaging</subject><subj-group><subject>Single Photon Emission Computed Tomography</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Neuroscience</subject><subj-group><subject>Neuroimaging</subject><subj-group><subject>Single Photon Emission Computed Tomography</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Diagnostic Medicine</subject><subj-group><subject>Diagnostic Radiology</subject><subj-group><subject>Tomography</subject><subj-group><subject>Single Photon Emission Computed Tomography</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Imaging Techniques</subject><subj-group><subject>Diagnostic Radiology</subject><subj-group><subject>Tomography</subject><subj-group><subject>Single Photon Emission Computed Tomography</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Radiology and Imaging</subject><subj-group><subject>Diagnostic Radiology</subject><subj-group><subject>Tomography</subject><subj-group><subject>Single Photon Emission Computed Tomography</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Cancer Treatment</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Imaging Techniques</subject><subj-group><subject>Neuroimaging</subject><subj-group><subject>Computed Axial Tomography</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Neuroscience</subject><subj-group><subject>Neuroimaging</subject><subj-group><subject>Computed Axial Tomography</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Diagnostic Medicine</subject><subj-group><subject>Diagnostic Radiology</subject><subj-group><subject>Tomography</subject><subj-group><subject>Computed Axial Tomography</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Imaging Techniques</subject><subj-group><subject>Diagnostic Radiology</subject><subj-group><subject>Tomography</subject><subj-group><subject>Computed Axial Tomography</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Radiology and Imaging</subject><subj-group><subject>Diagnostic Radiology</subject><subj-group><subject>Tomography</subject><subj-group><subject>Computed Axial Tomography</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Cancer Treatment</subject><subj-group><subject>Radiation Therapy</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Clinical Medicine</subject><subj-group><subject>Clinical Oncology</subject><subj-group><subject>Radiation Therapy</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Clinical Oncology</subject><subj-group><subject>Radiation Therapy</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Cancers and Neoplasms</subject><subj-group><subject>Lung and Intrathoracic Tumors</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Cancers and Neoplasms</subject><subj-group><subject>Lung and Intrathoracic Tumors</subject><subj-group><subject>Secondary Lung Tumors</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Health Care</subject></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pharmacology</subject><subj-group><subject>Radiopharmaceuticals</subject></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Quantitative accuracy of <sup>177</sup>Lu SPECT imaging for molecular
radiotherapy</article-title><alt-title alt-title-type="running-head"><sup>177</sup>Lu SPECT imaging and gamma
camera calibration</alt-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-0150-7757</contrib-id><name><surname>Mezzenga</surname><given-names>Emilio</given-names></name><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Resources</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026;
editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib><contrib contrib-type="author"><name><surname>D&#x02019;Errico</surname><given-names>Vincenzo</given-names></name><role content-type="http://credit.casrai.org/">Resources</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>D&#x02019;Arienzo</surname><given-names>Marco</given-names></name><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026;
editing</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Strigari</surname><given-names>Lidia</given-names></name><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026;
editing</role><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Panagiota</surname><given-names>Koutla</given-names></name><role content-type="http://credit.casrai.org/">Investigation</role><xref ref-type="aff" rid="aff004"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Matteucci</surname><given-names>Federica</given-names></name><role content-type="http://credit.casrai.org/">Visualization</role><xref ref-type="aff" rid="aff005"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Severi</surname><given-names>Stefano</given-names></name><role content-type="http://credit.casrai.org/">Visualization</role><xref ref-type="aff" rid="aff005"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Paganelli</surname><given-names>Giovanni</given-names></name><role content-type="http://credit.casrai.org/">Visualization</role><xref ref-type="aff" rid="aff005"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Fenwick</surname><given-names>Andrew</given-names></name><role content-type="http://credit.casrai.org/">Supervision</role><xref ref-type="aff" rid="aff006"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Bianchini</surname><given-names>David</given-names></name><role content-type="http://credit.casrai.org/">Visualization</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Marcocci</surname><given-names>Francesco</given-names></name><role content-type="http://credit.casrai.org/">Visualization</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Sarnelli</surname><given-names>Anna</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026;
editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>Medical Physics Unit, Istituto Scientifico Romagnolo per lo Studio e la
Cura dei Tumori (IRST) IRCCS, Meldola, Italy</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>National Institute of Ionizing Radiation Metrology, ENEA CR Casaccia,
Rome, Italy</addr-line></aff><aff id="aff003"><label>3</label>
<addr-line>Laboratory of Medical Physics and Expert Systems, Regina Elena National
Cancer Institute, Rome, Italy</addr-line></aff><aff id="aff004"><label>4</label>
<addr-line>Department of Physics, Aristotle University of Thessaloniki,
Thessaloniki, Greece</addr-line></aff><aff id="aff005"><label>5</label>
<addr-line>Nuclear Medicine Unit, Istituto Scientifico Romagnolo per lo Studio e la
Cura dei Tumori (IRST) IRCCS, Meldola, Italy</addr-line></aff><aff id="aff006"><label>6</label>
<addr-line>National Physical Laboratory, Hampton Road, Teddington, United
Kingdom</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Chen</surname><given-names>Chin-Tu</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>University of Chicago, UNITED STATES</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><corresp id="cor001">* E-mail: <email>emilio.mezzenga@irst.emr.it</email></corresp></author-notes><pub-date pub-type="epub"><day>14</day><month>8</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>12</volume><issue>8</issue><elocation-id>e0182888</elocation-id><history><date date-type="received"><day>27</day><month>6</month><year>2016</year></date><date date-type="accepted"><day>26</day><month>7</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; 2017 Mezzenga et al</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Mezzenga et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the
<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>,
which permits unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pone.0182888.pdf"/><abstract><p>The purpose of this study is to investigate the optimal reference geometry for
gamma camera calibration. Yet another question of interest was to assess the
influence of the number of 3D Ordered Subsets Expectation Maximization (3D-OSEM)
updates on activity quantification for SPECT imaging with <sup>177</sup>Lu. The
accuracy of <sup>177</sup>Lu activity quantification was assessed both in small
and in large objects. Two different reference geometries, namely a cylindrical
homogeneous phantom and a Jaszczak 16 ml sphere surrounded by cold water, were
used to determine the gamma camera calibration factor of a commercial SPECT/CT
system. Moreover, the noise level and the concentration recovery coefficient
were evaluated as a function of the number of 3D-OSEM updates by using the
SPECT/CT images of the reference geometry phantoms and those of a cold Jaszczak
phantom with three hot spheres (16ml, 8ml and 4ml), respectively. The optimal
choice of the number of 3D-OSEM updates was based on a compromise between the
noise level achievable in the reconstructed SPECT images and the concentration
recovery coefficients. The quantitative accuracy achievable was finally
validated on a test phantom, where a spherical insert composed of two concentric
spheres was used to simulate a lesion in a warm background. Our data confirm and
extend previous observations. Using the calibration factor obtained with the
cylindrical homogeneous phantom and the Jaszczak 16 ml sphere, the recovered
activity in the test phantom was underestimated by -16.4% and -24.8%,
respectively. Our work has led us to conclude that gamma camera calibration
performed with large homogeneous phantom outperforms calibration executed with
the Jaszczak 16ml sphere. Furthermore, the results obtained support the
assumption that approximately 50 OSEM updates represent a good trade-off to
reach convergence in small volumes, meanwhile minimizing the noise level.</p></abstract><funding-group><funding-statement>The authors received no specific funding for this
work.</funding-statement></funding-group><counts><fig-count count="6"/><table-count count="3"/><page-count count="18"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the paper and its Supporting
Information files.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the paper and its Supporting
Information files.</p></notes></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p>In recent years, molecular radiotherapy (MRT) based on peptide receptor radionuclide
therapy has gained popularity for treatment of neuroendocrine tumors [<xref rid="pone.0182888.ref001" ref-type="bibr">1</xref>&#x02013;<xref rid="pone.0182888.ref004" ref-type="bibr">4</xref>]. In particular, peptides labeled with
Lutetium-177 (<sup>177</sup>Lu) have gained today an established use in the
treatment of this disease [<xref rid="pone.0182888.ref005" ref-type="bibr">5</xref>&#x02013;<xref rid="pone.0182888.ref010" ref-type="bibr">10</xref>]. In
addition, encouraging results have also been obtained with theranostic
radiopharmaceuticals in metastatic prostate cancer patients, indicating that the use
and importance of <sup>177</sup>Lu is expected to increase in the coming years also
in the management of these patients [<xref rid="pone.0182888.ref011" ref-type="bibr">11</xref>&#x02013;<xref rid="pone.0182888.ref014" ref-type="bibr">14</xref>]. Even if
promising results are obtained in terms of treatment outcomes from patients treated
with <sup>177</sup>Lu using fixed activities, it is expected that personalized dose
assessment could further improve the clinical outcomes in terms of the tumor control
and reduction of the normal tissue effects.</p><p>From the physical point of view, <sup>177</sup>Lu has several pros: (a) a
concentrated energy deposition due to its low-energy beta emissions; (b) a favorable
half-life; (c) a gamma emissions enabling imaging to evaluate the radiotracer
biodistribution. A preliminary mandatory step to perform personalized dosimetry
relies on the possibility of having accurate quantitative information from
reconstructed images [<xref rid="pone.0182888.ref015" ref-type="bibr">15</xref>,<xref rid="pone.0182888.ref016" ref-type="bibr">16</xref>]. In
particular, SPECT/CT systems have the potential of enabling the conversion from
counts in each voxel into activity values.</p><p>The general recommendations outlined on the Medical Internal Radiation Dose (MIRD)
pamphlet No. 23 [<xref rid="pone.0182888.ref017" ref-type="bibr">17</xref>] and No.
26 [<xref rid="pone.0182888.ref018" ref-type="bibr">18</xref>], the latter
specifically dedicated to <sup>177</sup>Lu dosimetry, do not state uniquely defined
procedures, protocols or correction factors. In addition, MIRD No. 26 highlighted
that high variations in voxel counts may depend on the reconstruction process and
not necessarily on the heterogeneous biologic uptake of the radiopharmaceutical
[<xref rid="pone.0182888.ref018" ref-type="bibr">18</xref>]. Along these lines,
MIRD No. 23 states that a larger or lower number of iterations should be used if the
mean absorbed dose or the dose volume histograms, respectively, are to be calculated
[<xref rid="pone.0182888.ref017" ref-type="bibr">17</xref>]. Consequently,
different calibration geometries, data acquisition and processing methods have been
adopted for obtaining the calibration of SPECT/CT scanner [<xref rid="pone.0182888.ref019" ref-type="bibr">19</xref>&#x02013;<xref rid="pone.0182888.ref023" ref-type="bibr">23</xref>].</p><p>Beauregard et al. [<xref rid="pone.0182888.ref019" ref-type="bibr">19</xref>]
validated a quantitative SPECT method using a commercially available SPECT/CT system
and its software supporting attenuation and scatter correction factors. De Nijs et
al. [<xref rid="pone.0182888.ref020" ref-type="bibr">20</xref>] investigated the
conversion factors from counts to activity focusing on the collimator type, the
energy windows and the scatter correction techniques. Sanders et al. [<xref rid="pone.0182888.ref021" ref-type="bibr">21</xref>] highlighted that the
calibration factor calculated for each set of reconstruction parameters (i.e. number
of iterations and subsets) was sensitive only to the choice of photopeak (113 keV vs
208 keV). Scherbinin et al. [<xref rid="pone.0182888.ref022" ref-type="bibr">22</xref>] examined the ability of different methods including attenuation and
scatter correction, resolution loss and contamination in order to accurately
reconstruct the distributions of <sup>177</sup>Lu activity. Hippel&#x000e4;inen et al.
[<xref rid="pone.0182888.ref023" ref-type="bibr">23</xref>] found higher
concentration recovery coefficients when the attenuation, collimator-detector
response and scatter correction were applied to the reconstruction of images of an
anthropomorphic phantom. Finally, Zeintl et al. [<xref rid="pone.0182888.ref024" ref-type="bibr">24</xref>] used quasi-analytic simulation of
cross-calibrated clinical SPECT/CT to determine the correction factors to be applied
to reconstructed images.</p><p>In this context, our work focuses on the investigation of two different reference
geometries for SPECT calibration and on the image reconstruction process in order to
evaluate the percent deviation in small volumes for dosimetry purposes. To the best
of our knowledge, the relation between the noise level and strategy of
reconstruction in the accuracy of quantitative SPECT imaging using <sup>177</sup>Lu
has never been investigated in such a complex geometry.</p><p>For the sake of consistency, the present work has been organized into three
sections:</p><list list-type="order"><list-item><p>the first part deals with the implementation of two different reference
geometries (easy to be implemented in the clinical practice) for SPECT
calibration, considering different image reconstruction parameters (i.e.
number of 3D-OSEM updates);</p></list-item><list-item><p>the second part of the paper aims to establish the concentration recovery
coefficients for spherical objects and study the impact of noise level as a
function of the number of 3D-OSEM updates, using the calibration factors
previously assessed. The optimal choice of the number of 3D-OSEM updates is
based on a compromise between the noise level achievable in the
reconstructed SPECT images and the concentration recovery coefficients;</p></list-item><list-item><p>finally, the quantification procedure analyzed in the previous steps was
validated in anthropomorphic geometry, i.e. a torso phantom provided with a
hot spherical shell mimicking a solid tumor surrounded by a fainter circular
area background.</p></list-item></list></sec><sec sec-type="materials|methods" id="sec002"><title>Materials and methods</title><sec id="sec003"><title>Reference calibration geometries and recovery coefficient phantom</title><p>Calibration of the SPECT system was performed by using two different reference
geometries: (a) a 6.4 l cylindrical homogeneous phantom (Data Spectrum
Corporation, Hillsborough, USA) filled with a <sup>177</sup>Lu concentration of
0.11 MBq/ml; (b) a Jaszczak sphere of 16 ml in volume filled with a
<sup>177</sup>Lu concentration of 30.3 MBq/ml, fixed to the bottom of a
cylindrical phantom (the same used in (a)) filled with cold water. Hereafter,
the reference geometry (a) will be indicated as homogeneous phantom (Hp, <xref ref-type="fig" rid="pone.0182888.g001">Fig 1A</xref>), while the reference
geometry (b) will be indicated as Jaszczak sphere phantom (Js, <xref ref-type="fig" rid="pone.0182888.g001">Fig 1B</xref>).</p><fig id="pone.0182888.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0182888.g001</object-id><label>Fig 1</label><caption><title>CT images of the phantoms used for SPECT calibration and activity
recovery evaluation.</title><p>From left to right: coronal (first column), sagittal (second column) and
transaxial (third column) CT views of A) Hp, B) Js and C) Rp phantom.
The insets shown in the third column refer to the different volumes of
interest (blue color) used for SPECT calibration (right inferior corner
of A) and B)), noise (left superior corner of A), together with the
location of VOI<sub>w</sub>) and activity recovery (right inferior
corner of C)).</p></caption><graphic xlink:href="pone.0182888.g001"/></fig><p>Finally, a third phantom (hereafter called Recovery phantom&#x02014;Rp, <xref ref-type="fig" rid="pone.0182888.g001">Fig 1C</xref>) was used to assess the
concentration recovery coefficients in spherical objects. The phantom is
composed by three spheres of different volumes (16ml, 8ml and 4ml), each one
filled with a <sup>177</sup>Lu concentration of 1.13 MBq/ml and fixed to the
bottom of a cylindrical phantom filled with cold water.</p><p>For these three phantoms, the accuracy of activity was assessed by means of the
clinically available dose calibrator with an uncertainty of about 5%, and the
activity concentration was referred to the time of SPECT acquisition.</p><p>The SPECT dead time was assessed using the dual source method, according to
[<xref rid="pone.0182888.ref025" ref-type="bibr">25</xref>,<xref rid="pone.0182888.ref026" ref-type="bibr">26</xref>], and dead time
corrections were evaluated for Hp and Js and applied to the reconstructed
images.</p></sec><sec id="sec004"><title>Validation geometry</title><p>In order to assess the quantitative accuracy of our procedure for recovering the
activity of small volume objects mimicking tumor lesions (i.e. high uptake
region surrounded by a fainter region), a validation anthropomorphic phantom was
used (<xref ref-type="fig" rid="pone.0182888.g002">Fig 2</xref>).</p><fig id="pone.0182888.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0182888.g002</object-id><label>Fig 2</label><caption><title>Validation anthropomorphic phantom.</title><p>A) Coronal, B) sagittal and C) transaxial CT views of the validation
anthropomorphic phantom. D) transaxial view of fused SPECT/CT
images.</p></caption><graphic xlink:href="pone.0182888.g002"/></fig><p>Specifically, we used an elliptical Jaszczak phantom representative of realistic
clinical conditions. The phantom was provided with lungs, body contour rings,
spine compartment and a spherical insert (representative of a tumor lesion) made
of two concentric spheres. The spine insert was filled with bone equivalent
solution of dipotassium hydrogen orthophosphate (K<sub>2</sub>HPO<sub>4</sub>)
and the lungs were filled with lung equivalent material. In between the two
lungs, the spherical insert composed of two concentric spheres of different
volumes was placed and attached to the base plate of the phantom with the
purpose to simulate a solid tumor (internal sphere, 18.3 mm diameter) with a
fainter background region (external shell, 27.8 mm diameter). The inner sphere
and the spherical shell were filled with an activity concentration of 2.7 MBq/ml
and 0.2 MBq/ml, respectively. The remaining volume of the phantom was filled
with cold water.</p></sec><sec id="sec005"><title>SPECT/CT acquisition protocol</title><p>All acquisitions were performed using a hybrid SPECT/CT system (Discovery NM/CT
670, GE Healthcare, Milwaukee, USA), equipped with two gamma detector heads (9.5
mm NaI(Tl) crystal thickness of 40 cm axial by 54 cm diameter field of view),
and an integrated CT component identical to a 16-slice-CT used in diagnostic CT
imaging (model: Bright Speed 16, GE Healthcare, Milwaukee, USA). SPECT
acquisitions were performed using the following parameters: 120 projections with
180&#x000b0; mode detector head, 30 seconds per projection, non-circular step-and-shot
acquisition orbit, 128&#x000d7;128 matrix and 4.42&#x000d7;4.42 mm pixel size. For scatter
correction, projection data were acquired in three energy windows using a
parallel-hole medium energy general purpose (MEGP) collimator: a symmetrical 20%
wide energy window was centered at 208 keV <sup>177</sup>Lu photopeak (energy
window:187.2 keV-228.8 keV), together with two 8.7% and 11.8% wide adjacent
scatter windows, providing the upper and lower scatter windows, respectively.
The SPECT acquisition was followed by a CT scan (120 kV, 80mAs, 1.375 pitch,
16x1.25 mm collimation, 3.75 slice thickness reconstruction). CT images were
reconstructed with filtered back projection algorithm using the default
convolution kernel for routine low dose CT (LD-CT) examination of abdomen.</p></sec><sec id="sec006"><title>Image reconstructions</title><p>SPECT/CT data processing was carried out on a dedicated workstation (Xeleris
3.1108, GE Healthcare, Milwaukee, USA), provided with a software from the same
vendor (Dosimetry Toolkit Package, GE Healthcare, Milwaukee, USA). It
reconstructs the SPECT images by means of 3D-OSEM algorithm [<xref rid="pone.0182888.ref027" ref-type="bibr">27</xref>] including resolution
recovery, scatter correction and attenuation correction. This last correction
was performed by linear attenuation coefficient (&#x003bc;) maps estimated from the
acquired LD-CT. Reconstruction of SPECT images was performed by considering 5,
10, 15, 20 and 30 subsets, with a number of iterations from 1 to 7 with an
incremental step of 1, and from 10 to 50 with a incremental step of 5. A total
of 80 combinations have been considered for SPECT images related to the
reference geometries. No pre- and post-reconstruction filters were used, and, at
the end of the reconstruction process, the software re-bins the CT matrix to the
SPECT one giving a 256&#x000d7;256 matrix dataset with a 2.21 mm isotropic voxel.</p></sec><sec id="sec007"><title>Data analysis</title><p>All reconstructed SPECT images have been processed with MATLAB (The Mathworks,
Inc., MA, US). For Hp, a cylindrical volume of interest (VOI) of about 2.0 l was
used to calculate the calibration factor. To minimize the edge effects the VOI
was designed with a minimum distance of 3 cm set from the inner boundaries of
the phantom (<xref ref-type="fig" rid="pone.0182888.g001">Fig 1A</xref>, inset
at the bottom right corner). For Js, the CT-based contour of the 16 ml sphere
was isotropically expanded and a spherical VOI of 6 cm diameter was used for the
calculation of the calibration factor (<xref ref-type="fig" rid="pone.0182888.g001">Fig 1B</xref>, inset at the bottom right corner).
The total counts inside the VOIs were recorded for each combination of subset
(<italic>s</italic>) and iteration (<italic>i</italic>) (hereafter the
product <italic>s</italic> x <italic>i</italic> will be referred as equivalent
iterations&#x02014;<italic>EI</italic>). The SPECT calibration factor (or
sensitivity&#x02014;<italic>S</italic>), expressed in units of counts-per-second/MBq
(cps/MBq) was calculated using Eq (<xref ref-type="disp-formula" rid="pone.0182888.e001">1</xref>) [<xref rid="pone.0182888.ref015" ref-type="bibr">15</xref>]: <disp-formula id="pone.0182888.e001"><alternatives><graphic xlink:href="pone.0182888.e001.jpg" id="pone.0182888.e001g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M1"><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>(</mml:mo><mml:mrow><mml:mi>E</mml:mi><mml:mi>I</mml:mi></mml:mrow><mml:mo>)</mml:mo><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>(</mml:mo><mml:mrow><mml:mi>E</mml:mi><mml:mi>I</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>V</mml:mi><mml:mi>O</mml:mi><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>c</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mspace width="2em"/><mml:mrow><mml:mo>{</mml:mo><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mspace width="0.25em"/><mml:mi>f</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mspace width="0.25em"/><mml:mi>H</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>2</mml:mn><mml:mspace width="0.25em"/><mml:mi>f</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mspace width="0.5em"/><mml:mi>J</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives><label>(1)</label></disp-formula> where <italic>V</italic><sub><italic>VOIj</italic></sub> is the
volume of the considered VOI, <italic>c</italic><sub><italic>j</italic></sub>
the activity concentration inside the phantom volume, and
<italic>R</italic><sub><italic>j</italic></sub><italic>(EI)</italic> the
decay-corrected counting rate [<xref rid="pone.0182888.ref024" ref-type="bibr">24</xref>] function of the considered <italic>EI</italic>.</p><p>The image noise for both reference geometries was evaluated by means of the
coefficient of variation (<italic>COV</italic>), defined as the ratio between
the standard deviation (<italic>s</italic>) and the average (<italic>M</italic>)
of voxel counts inside the VOIs considered [<xref rid="pone.0182888.ref021" ref-type="bibr">21</xref>,<xref rid="pone.0182888.ref028" ref-type="bibr">28</xref>]. In particular, for Hp twelve 16 ml
spherical VOIs (left superior corner of <xref ref-type="fig" rid="pone.0182888.g001">Fig 1A</xref>) were drawn at a distance of 15 mm
from the edge of the phantom, and for each VOI<sub>w</sub> (<italic>w</italic> =
1, 2, &#x02026;, 12, see inset in left superior corner of <xref ref-type="fig" rid="pone.0182888.g001">Fig 1A</xref>) the <italic>COV</italic> was
evaluated as reported in Eq (<xref ref-type="disp-formula" rid="pone.0182888.e002">2</xref>): <disp-formula id="pone.0182888.e002"><alternatives><graphic xlink:href="pone.0182888.e002.jpg" id="pone.0182888.e002g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M2"><mml:msub><mml:mrow><mml:mi>C</mml:mi><mml:mi>O</mml:mi><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mi>w</mml:mi></mml:mrow></mml:msub><mml:mo>(</mml:mo><mml:mrow><mml:mi>E</mml:mi><mml:mi>I</mml:mi></mml:mrow><mml:mo>)</mml:mo><mml:mi mathvariant="normal">%</mml:mi><mml:mo>=</mml:mo><mml:mn>100</mml:mn><mml:mo>&#x000d7;</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>w</mml:mi></mml:mrow></mml:msub><mml:mo>(</mml:mo><mml:mrow><mml:mi>E</mml:mi><mml:mi>I</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>M</mml:mi></mml:mrow><mml:mrow><mml:mi>w</mml:mi></mml:mrow></mml:msub><mml:mo>(</mml:mo><mml:mrow><mml:mi>E</mml:mi><mml:mi>I</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mfrac></mml:math></alternatives><label>(2)</label></disp-formula></p><p>The <italic>COV</italic> related to the Hp geometry was evaluated as the mean
value of the <italic>COV</italic><sub><italic>w</italic></sub>. A 16 ml
spherical VOI was chosen for Hp in analogy with the <italic>COV</italic>
evaluation performed for Js. In fact, in this last calibration geometry a
spherical VOI based on the CT-contour of the 16 ml sphere was considered, and
the <italic>COV</italic> was evaluated according to Eq (<xref ref-type="disp-formula" rid="pone.0182888.e002">2</xref>) for
<italic>w</italic> = 1.</p><p>To estimate the quantitative accuracy achievable using the two calibration
factors, the reconstructed SPECT images of the Rp were used to determine the
concentration recovery coefficient (<italic>cRC</italic>) of each spheres
considered. The <italic>cRC</italic> was estimated according to Eq (<xref ref-type="disp-formula" rid="pone.0182888.e003">3</xref>) [<xref rid="pone.0182888.ref021" ref-type="bibr">21</xref>]: <disp-formula id="pone.0182888.e003"><alternatives><graphic xlink:href="pone.0182888.e003.jpg" id="pone.0182888.e003g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M3"><mml:msub><mml:mrow><mml:mi>c</mml:mi><mml:mi>R</mml:mi><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>(</mml:mo><mml:mrow><mml:mi>E</mml:mi><mml:mi>I</mml:mi></mml:mrow><mml:mo>)</mml:mo><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mo>(</mml:mo><mml:mrow><mml:mi>E</mml:mi><mml:mi>I</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>&#x02219;</mml:mo><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>(</mml:mo><mml:mrow><mml:mi>E</mml:mi><mml:mi>I</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mfrac></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mi>c</mml:mi></mml:mrow></mml:mfrac><mml:mspace width="1em"/><mml:mrow><mml:mo>{</mml:mo><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mspace width="1em"/><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>16</mml:mn><mml:mspace width="0.25em"/><mml:mi>m</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mspace width="0.75em"/><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>8</mml:mn><mml:mspace width="0.25em"/><mml:mi>m</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mspace width="0.75em"/><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>4</mml:mn><mml:mspace width="0.25em"/><mml:mi>m</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives><label>(3)</label></disp-formula> where
<italic>R</italic><sub><italic>k</italic></sub><italic>(EI</italic>) is the
count rate inside the CT-based contours of <italic>k</italic>-th sphere (<xref ref-type="fig" rid="pone.0182888.g001">Fig 1C</xref>, bottom right corner),
<italic>S</italic><sub><italic>j</italic></sub><italic>(EI)</italic> the
calculated SPECT calibration factor related to the <italic>j</italic>-th
reference geometry, <italic>V</italic><sub><italic>k</italic></sub> the VOI
related to the <italic>k</italic>-th sphere, and <italic>c</italic> refers to
the sphere&#x02019;s concentration.</p><p>The validation of the quantification procedure was performed with the
anthropomorphic phantom (<xref ref-type="fig" rid="pone.0182888.g002">Fig
2</xref>) and the inner spherical insert, mimicking tumor lesions, was
considered as a bench test. The difference between the true injected activity
(<italic>A</italic><sub><italic>T</italic></sub>) and the reconstructed one
(<italic>A</italic><sub><italic>R</italic></sub>) was estimated according to
Eq (<xref ref-type="disp-formula" rid="pone.0182888.e004">4</xref>):
<disp-formula id="pone.0182888.e004"><alternatives><graphic xlink:href="pone.0182888.e004.jpg" id="pone.0182888.e004g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M4"><mml:msub><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>100</mml:mn><mml:mo>*</mml:mo><mml:mfrac><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>A</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>(</mml:mo><mml:mrow><mml:mi>E</mml:mi><mml:mi>I</mml:mi></mml:mrow><mml:mo>)</mml:mo><mml:mo>&#x02212;</mml:mo><mml:msub><mml:mrow><mml:mi>A</mml:mi></mml:mrow><mml:mrow><mml:mi>T</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>A</mml:mi></mml:mrow><mml:mrow><mml:mi>T</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mspace width="1em"/><mml:mrow><mml:mo>{</mml:mo><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mspace width="0.25em"/><mml:mi>f</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mspace width="0.25em"/><mml:mi>H</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>2</mml:mn><mml:mspace width="0.25em"/><mml:mi>f</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mspace width="0.5em"/><mml:mi>J</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives><label>(4)</label></disp-formula> where
<italic>A</italic><sub><italic>R</italic></sub><italic>(EI)</italic> was
calculated from the totals counts inside the CT-based contours of the inner
spherical insert, converted into activity by using <italic>S</italic> values
(<xref ref-type="disp-formula" rid="pone.0182888.e001">Eq 1</xref>) for the
Hp and Js geometries.</p></sec></sec><sec sec-type="results" id="sec008"><title>Results</title><p><xref ref-type="fig" rid="pone.0182888.g003">Fig 3</xref> shows the calibration
factors (<italic>S</italic>) as a function of <italic>EI</italic> obtained for A) Hp
and B) Js, respectively. Each plot refers to the number of subsets chosen, as
reported in the legend. For completeness and clarity of the results, the insets
highlight the trend of the dataplots for a restricted interval of <italic>S</italic>
and <italic>EI</italic>. In case of Hp (<xref ref-type="fig" rid="pone.0182888.g003">Fig 3A</xref>), for all subsets the <italic>S</italic> values increase as a
function of <italic>EI</italic> for <italic>EI</italic>&#x0003c;100, while for
<italic>EI</italic>&#x0003e;100 the <italic>S</italic> values decreases as a function
of <italic>EI</italic>, untill a plateau is reached. In the case of Js (<xref ref-type="fig" rid="pone.0182888.g003">Fig 3B</xref>), the <italic>S</italic>
values decrease with increasing <italic>EIs</italic>, untill a plateau is reached
for 15, 20 and 30 subsets, while for 5 and 10 subsets the data trend is similar to
Hp one, but the S plateau is reached for EI&#x0003e;200.These different trends can be
ascribed to the different volume of the Hp and Js geometries [<xref rid="pone.0182888.ref018" ref-type="bibr">18</xref>]. In fact, fixing the number of subsets, the
EI required for convergence depend on the volume: hence, the plateaus of S start
from different EI values for Hp and Js geometries.</p><fig id="pone.0182888.g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0182888.g003</object-id><label>Fig 3</label><caption><title>SPECT calibration factors versus <italic>EI</italic>.</title><p>Calibration factors (<italic>S</italic>) as a function of <italic>EI</italic>
for A) Hp and B) Js geometries, respectively. The insets reported are zoom
views of the initial <italic>S</italic> trend versus
<italic>EI</italic>.</p></caption><graphic xlink:href="pone.0182888.g003"/></fig><p><xref ref-type="fig" rid="pone.0182888.g004">Fig 4</xref> shows the
<italic>COV</italic> values as a function of <italic>EI</italic> for A) Hp and
B) Js geometries, respectively, for all subsets of interest. In order to highlight
the dependence between <italic>COV</italic> and the number of subsets and
iterations, the <italic>COV</italic> data are reported as a function of the number
of iterations in the insets of <xref ref-type="fig" rid="pone.0182888.g004">Fig
4</xref> for A) Hp and B) Js geometries and in <xref ref-type="table" rid="pone.0182888.t001">Table 1</xref> and <xref ref-type="table" rid="pone.0182888.t002">Table 2</xref>, respectively. The data trend shown in
<xref ref-type="fig" rid="pone.0182888.g004">Fig 4A</xref> confirms the expected
influence of 3D-OSEM algorithm on noise values in the SPECT images: fixing the
number of subsets, the larger the number of iterations the larger the
<italic>COV</italic>, and the same happens fixing the number of iterations (see
also data in <xref ref-type="table" rid="pone.0182888.t001">Table 1</xref>).
Differently, in the case of Js (<xref ref-type="fig" rid="pone.0182888.g004">Fig
4B</xref>) and for all subsets, the <italic>COV</italic> reaches a minimum in
the range between 50 and 150 <italic>EI</italic>, that is approximately constant and
equals roughly to 12%. After this <italic>EI</italic> range, the Js
<italic>COV</italic> increases with the same trend shown in <xref ref-type="fig" rid="pone.0182888.g004">Fig 4A</xref>. The information about the number of
iterations at which the <italic>COV</italic> reaches its minimum can be derived for
each number of subsets from the insets of <xref ref-type="fig" rid="pone.0182888.g004">Fig 4B</xref> and <xref ref-type="table" rid="pone.0182888.t002">Table 2</xref>. The different <italic>COV</italic>
trends observed for Hp and Js are the results of the 3D-OSEM algorithm applied to
the different volumes. Furthermore, the Hp <italic>COV</italic> provides information
about the noise level in large anatomical regions where the radiopharmaceutical is
supposed to be uniformly distributed (i.e. tissues or organs with uniform uptake of
the radionuclide), while the Js <italic>COV</italic> provides the same information
for a small volume, such as a lesion&#x02019;s volume inside the patient. As a general rule,
the noise behavior in the phantom will be highly local due to the fact that
convergence occurs at different rates at different points in the image. Therefore,
we studied the dependence of <italic>COV</italic> as a function of VOI location
inside the Hp phantom (left superior corner of <xref ref-type="fig" rid="pone.0182888.g001">Fig 1A</xref>), varying the number of
<italic>EI</italic>. The standard deviation of the twelve <italic>COV</italic>
values (estimated considering the <italic>VOI</italic><sub><italic>w</italic></sub>)
represents the error that affect the noise measurements when a single VOI is chosen.
Fixing the number of subsets, the standard deviation increases as the number of
iterations increases, ranging between 0.7% (at <italic>EI</italic> equals to 5, i.e.
5<italic>s</italic>x1<italic>i</italic>) and 9.8% (at <italic>EI</italic> equals
to 1500, i.e. 30<italic>s</italic>x50<italic>i</italic>). Based on these results, it
is reasonable to assume that the error affecting the <italic>COV</italic> estimation
for Js geometry is comparable to that for Hp one. Moreover, these results support
the hypothesis that noise becomes dominant with increasing <italic>EIs</italic>.</p><fig id="pone.0182888.g004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0182888.g004</object-id><label>Fig 4</label><caption><title>Relationship between <italic>COV</italic> and
<italic>EI</italic>.</title><p><italic>COV</italic> as a function of <italic>EI</italic> and the subsets
considered for A) Hp and B) Js geometry. The insets show the
<italic>COV</italic> values as a function of the number of
iterations.</p></caption><graphic xlink:href="pone.0182888.g004"/></fig><table-wrap id="pone.0182888.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0182888.t001</object-id><label>Table 1</label><caption><title>Results of the noise values for the Hp reference geometry.</title></caption><alternatives><graphic id="pone.0182888.t001g" xlink:href="pone.0182888.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">iterations</th><th align="center" rowspan="1" colspan="1">5-subsets</th><th align="center" rowspan="1" colspan="1">10-subsets</th><th align="center" rowspan="1" colspan="1">15-subsets</th><th align="center" rowspan="1" colspan="1">20-subsets</th><th align="center" rowspan="1" colspan="1">30-subsets</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">1</td><td align="right" rowspan="1" colspan="1">4.58%<xref ref-type="table-fn" rid="t001fn001">*</xref></td><td align="right" rowspan="1" colspan="1">5.95%<xref ref-type="table-fn" rid="t001fn001">*</xref></td><td align="right" rowspan="1" colspan="1">6.72%<xref ref-type="table-fn" rid="t001fn001">*</xref></td><td align="right" rowspan="1" colspan="1">9.47%<xref ref-type="table-fn" rid="t001fn001">*</xref></td><td align="right" rowspan="1" colspan="1">11.88%<xref ref-type="table-fn" rid="t001fn001">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">2</td><td align="right" rowspan="1" colspan="1">6.46%<xref ref-type="table-fn" rid="t001fn001">*</xref></td><td align="right" rowspan="1" colspan="1">8.86% <xref ref-type="table-fn" rid="t001fn001">*</xref></td><td align="right" rowspan="1" colspan="1">9.82%<xref ref-type="table-fn" rid="t001fn001">*</xref></td><td align="right" rowspan="1" colspan="1">13.72%<xref ref-type="table-fn" rid="t001fn001">*</xref></td><td align="right" rowspan="1" colspan="1">17.51%</td></tr><tr><td align="left" rowspan="1" colspan="1">3</td><td align="right" rowspan="1" colspan="1">8.21%<xref ref-type="table-fn" rid="t001fn001">*</xref></td><td align="right" rowspan="1" colspan="1">11.15% <xref ref-type="table-fn" rid="t001fn001">*</xref></td><td align="right" rowspan="1" colspan="1">12.37%<xref ref-type="table-fn" rid="t001fn001">*</xref></td><td align="right" rowspan="1" colspan="1">17.33%</td><td align="right" rowspan="1" colspan="1">22.08%</td></tr><tr><td align="left" rowspan="1" colspan="1">4</td><td align="right" rowspan="1" colspan="1">9.67%<xref ref-type="table-fn" rid="t001fn001">*</xref></td><td align="right" rowspan="1" colspan="1">13.20% <xref ref-type="table-fn" rid="t001fn001">*</xref></td><td align="right" rowspan="1" colspan="1">14.69% <xref ref-type="table-fn" rid="t001fn001">*</xref></td><td align="right" rowspan="1" colspan="1">20.48%</td><td align="right" rowspan="1" colspan="1">25.99%</td></tr><tr><td align="left" rowspan="1" colspan="1">5</td><td align="right" rowspan="1" colspan="1">10.99%<xref ref-type="table-fn" rid="t001fn001">*</xref></td><td align="right" rowspan="1" colspan="1">15.10% <xref ref-type="table-fn" rid="t001fn001">*</xref></td><td align="right" rowspan="1" colspan="1">17.01%</td><td align="right" rowspan="1" colspan="1">23.29%</td><td align="right" rowspan="1" colspan="1">29.44%</td></tr><tr><td align="left" rowspan="1" colspan="1">6</td><td align="right" rowspan="1" colspan="1">12.23% <xref ref-type="table-fn" rid="t001fn001">*</xref></td><td align="right" rowspan="1" colspan="1">16.86% <xref ref-type="table-fn" rid="t001fn001">*</xref></td><td align="right" rowspan="1" colspan="1">18.78%</td><td align="right" rowspan="1" colspan="1">25.83%</td><td align="right" rowspan="1" colspan="1">32.53%</td></tr><tr><td align="left" rowspan="1" colspan="1">7</td><td align="right" rowspan="1" colspan="1">13.42% <xref ref-type="table-fn" rid="t001fn001">*</xref></td><td align="right" rowspan="1" colspan="1">18.51%</td><td align="right" rowspan="1" colspan="1">20.60%</td><td align="right" rowspan="1" colspan="1">28.18%</td><td align="right" rowspan="1" colspan="1">35.37%</td></tr><tr><td align="left" rowspan="1" colspan="1">10</td><td align="right" rowspan="1" colspan="1">16.87% <xref ref-type="table-fn" rid="t001fn001">*</xref></td><td align="right" rowspan="1" colspan="1">23.24%</td><td align="right" rowspan="1" colspan="1">25.83%</td><td align="right" rowspan="1" colspan="1">34.99%</td><td align="right" rowspan="1" colspan="1">43.70%</td></tr><tr><td align="left" rowspan="1" colspan="1">15</td><td align="right" rowspan="1" colspan="1">21.63%</td><td align="right" rowspan="1" colspan="1">29.48%</td><td align="right" rowspan="1" colspan="1">32.63%</td><td align="right" rowspan="1" colspan="1">43.51%</td><td align="right" rowspan="1" colspan="1">53.90%</td></tr><tr><td align="left" rowspan="1" colspan="1">20</td><td align="right" rowspan="1" colspan="1">25.72%</td><td align="right" rowspan="1" colspan="1">34.69%</td><td align="right" rowspan="1" colspan="1">38.29%</td><td align="right" rowspan="1" colspan="1">50.51%</td><td align="right" rowspan="1" colspan="1">62.24%</td></tr><tr><td align="left" rowspan="1" colspan="1">25</td><td align="right" rowspan="1" colspan="1">29.32%</td><td align="right" rowspan="1" colspan="1">39.21%</td><td align="right" rowspan="1" colspan="1">43.18%</td><td align="right" rowspan="1" colspan="1">56.54%</td><td align="right" rowspan="1" colspan="1">69.38%</td></tr><tr><td align="left" rowspan="1" colspan="1">30</td><td align="right" rowspan="1" colspan="1">32.56%</td><td align="right" rowspan="1" colspan="1">43.24%</td><td align="right" rowspan="1" colspan="1">47.54%</td><td align="right" rowspan="1" colspan="1">61.88%</td><td align="right" rowspan="1" colspan="1">75.64%</td></tr><tr><td align="left" rowspan="1" colspan="1">35</td><td align="right" rowspan="1" colspan="1">35.51%</td><td align="right" rowspan="1" colspan="1">46.90%</td><td align="right" rowspan="1" colspan="1">51.50%</td><td align="right" rowspan="1" colspan="1">66.69%</td><td align="right" rowspan="1" colspan="1">81.22%</td></tr><tr><td align="left" rowspan="1" colspan="1">40</td><td align="right" rowspan="1" colspan="1">38.23%</td><td align="right" rowspan="1" colspan="1">50.26%</td><td align="right" rowspan="1" colspan="1">55.13%</td><td align="right" rowspan="1" colspan="1">71.09%</td><td align="right" rowspan="1" colspan="1">83.93%</td></tr><tr><td align="left" rowspan="1" colspan="1">45</td><td align="right" rowspan="1" colspan="1">40.77%</td><td align="right" rowspan="1" colspan="1">53.38%</td><td align="right" rowspan="1" colspan="1">58.50%</td><td align="right" rowspan="1" colspan="1">75.14%</td><td align="right" rowspan="1" colspan="1">88.32%</td></tr><tr><td align="left" rowspan="1" colspan="1">50</td><td align="right" rowspan="1" colspan="1">43.15%</td><td align="right" rowspan="1" colspan="1">56.30%</td><td align="right" rowspan="1" colspan="1">61.65%</td><td align="right" rowspan="1" colspan="1">78.89%</td><td align="right" rowspan="1" colspan="1">92.29%</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t001fn001"><p>&#x02217;Combinations of iterations and subsets with a noise level lower than
17%.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pone.0182888.t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0182888.t002</object-id><label>Table 2</label><caption><title>Results of the noise values for the Js reference geometry.</title></caption><alternatives><graphic id="pone.0182888.t002g" xlink:href="pone.0182888.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">iterations</th><th align="center" rowspan="1" colspan="1">5-subsets</th><th align="center" rowspan="1" colspan="1">10-subsets</th><th align="center" rowspan="1" colspan="1">15-subsets</th><th align="center" rowspan="1" colspan="1">20-subsets</th><th align="center" rowspan="1" colspan="1">30-subsets</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">1</td><td align="right" rowspan="1" colspan="1">21.45%</td><td align="right" rowspan="1" colspan="1">20.58%</td><td align="right" rowspan="1" colspan="1">20.16%</td><td align="right" rowspan="1" colspan="1">18.21%</td><td align="right" rowspan="1" colspan="1">15.77%</td></tr><tr><td align="left" rowspan="1" colspan="1">2</td><td align="right" rowspan="1" colspan="1">20.26%</td><td align="right" rowspan="1" colspan="1">18.22%</td><td align="right" rowspan="1" colspan="1">17.08%<xref ref-type="table-fn" rid="t002fn001">*</xref></td><td align="right" rowspan="1" colspan="1">14.26%</td><td align="right" rowspan="1" colspan="1">12.60%</td></tr><tr><td align="left" rowspan="1" colspan="1">3</td><td align="right" rowspan="1" colspan="1">18.78%</td><td align="right" rowspan="1" colspan="1">15.82%<xref ref-type="table-fn" rid="t002fn001">*</xref></td><td align="right" rowspan="1" colspan="1">14.72%</td><td align="right" rowspan="1" colspan="1">12.69%</td><td align="right" rowspan="1" colspan="1">11.81%</td></tr><tr><td align="left" rowspan="1" colspan="1">4</td><td align="right" rowspan="1" colspan="1">17.17%</td><td align="right" rowspan="1" colspan="1">14.24%</td><td align="right" rowspan="1" colspan="1">13.38%</td><td align="right" rowspan="1" colspan="1">12.07%</td><td align="right" rowspan="1" colspan="1">11.62%</td></tr><tr><td align="left" rowspan="1" colspan="1">5</td><td align="right" rowspan="1" colspan="1">15.83%</td><td align="right" rowspan="1" colspan="1">13.27%</td><td align="right" rowspan="1" colspan="1">12.62%</td><td align="right" rowspan="1" colspan="1">11.82%</td><td align="right" rowspan="1" colspan="1">11.61%</td></tr><tr><td align="left" rowspan="1" colspan="1">6</td><td align="right" rowspan="1" colspan="1">14.79%<xref ref-type="table-fn" rid="t002fn001">*</xref></td><td align="right" rowspan="1" colspan="1">12.66%</td><td align="right" rowspan="1" colspan="1">12.18%</td><td align="right" rowspan="1" colspan="1">11.73%</td><td align="right" rowspan="1" colspan="1">11.69%</td></tr><tr><td align="left" rowspan="1" colspan="1">7</td><td align="right" rowspan="1" colspan="1">14.01%</td><td align="right" rowspan="1" colspan="1">12.28%</td><td align="right" rowspan="1" colspan="1">11.92%</td><td align="right" rowspan="1" colspan="1">11.72%</td><td align="right" rowspan="1" colspan="1">11.80%</td></tr><tr><td align="left" rowspan="1" colspan="1">10</td><td align="right" rowspan="1" colspan="1">12.66%</td><td align="right" rowspan="1" colspan="1">11.77%</td><td align="right" rowspan="1" colspan="1">11.64%</td><td align="right" rowspan="1" colspan="1">11.88%</td><td align="right" rowspan="1" colspan="1">12.22%</td></tr><tr><td align="left" rowspan="1" colspan="1">15</td><td align="right" rowspan="1" colspan="1">11.87%</td><td align="right" rowspan="1" colspan="1">11.67%</td><td align="right" rowspan="1" colspan="1">11.72%</td><td align="right" rowspan="1" colspan="1">12.35%</td><td align="right" rowspan="1" colspan="1">13.00%</td></tr><tr><td align="left" rowspan="1" colspan="1">20</td><td align="right" rowspan="1" colspan="1">11.68%</td><td align="right" rowspan="1" colspan="1">11.82%</td><td align="right" rowspan="1" colspan="1">11.97%</td><td align="right" rowspan="1" colspan="1">12.87%</td><td align="right" rowspan="1" colspan="1">13.73%</td></tr><tr><td align="left" rowspan="1" colspan="1">25</td><td align="right" rowspan="1" colspan="1">11.68%</td><td align="right" rowspan="1" colspan="1">12.03%</td><td align="right" rowspan="1" colspan="1">12.27%</td><td align="right" rowspan="1" colspan="1">13.37%</td><td align="right" rowspan="1" colspan="1">14.38%</td></tr><tr><td align="left" rowspan="1" colspan="1">30</td><td align="right" rowspan="1" colspan="1">11.75%</td><td align="right" rowspan="1" colspan="1">12.28%</td><td align="right" rowspan="1" colspan="1">12.58%</td><td align="right" rowspan="1" colspan="1">13.85%</td><td align="right" rowspan="1" colspan="1">14.96%</td></tr><tr><td align="left" rowspan="1" colspan="1">35</td><td align="right" rowspan="1" colspan="1">11.87%</td><td align="right" rowspan="1" colspan="1">12.53%</td><td align="right" rowspan="1" colspan="1">12.90%</td><td align="right" rowspan="1" colspan="1">14.30%</td><td align="right" rowspan="1" colspan="1">15.48%</td></tr><tr><td align="left" rowspan="1" colspan="1">40</td><td align="right" rowspan="1" colspan="1">12.00%</td><td align="right" rowspan="1" colspan="1">12.79%</td><td align="right" rowspan="1" colspan="1">13.21%</td><td align="right" rowspan="1" colspan="1">14.71%</td><td align="right" rowspan="1" colspan="1">15.95%</td></tr><tr><td align="left" rowspan="1" colspan="1">45</td><td align="right" rowspan="1" colspan="1">12.14%</td><td align="right" rowspan="1" colspan="1">13.05%</td><td align="right" rowspan="1" colspan="1">13.51%</td><td align="right" rowspan="1" colspan="1">15.10%</td><td align="right" rowspan="1" colspan="1">16.38%</td></tr><tr><td align="left" rowspan="1" colspan="1">50</td><td align="right" rowspan="1" colspan="1">12.29%</td><td align="right" rowspan="1" colspan="1">13.55%</td><td align="right" rowspan="1" colspan="1">13.91%</td><td align="right" rowspan="1" colspan="1">15.60%</td><td align="right" rowspan="1" colspan="1">16.88%</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t002fn001"><p>&#x02217;Combinations of iterations and subsets for which the
<italic>cRC</italic> plateaus start (<xref ref-type="fig" rid="pone.0182888.g005">Fig 5</xref> and <xref ref-type="fig" rid="pone.0182888.g006">Fig 6</xref>).</p></fn></table-wrap-foot></table-wrap><p>In order to minimize the <italic>COV</italic> in the reconstructed images, the lowest
<italic>EI</italic> values should be considered in the case of Hp geometry, as
the Hp <italic>COV</italic> monotonically increases as a function of
<italic>EI</italic>. In the case of the Js geometry, the <italic>EI</italic> at
which the <italic>COV</italic> reaches its minimum should be considered, as a
function of the subsets. In order to define a <italic>COV</italic> threshold
suitable for both situations (large and small volumes), an <italic>EI</italic> value
equal to 50 has been chosen because it corresponds to the lower bound of the
<italic>EI</italic> range in which the <italic>COV</italic> related to the Js
geometry is near to its minimum. For <italic>EI</italic> values equal to 50 the Hp
<italic>COV</italic> ranges between 15% (i.e.
10<italic>s</italic>x5<italic>i</italic>) and 17% (i.e.
5<italic>s</italic>x10<italic>i</italic>) as shown in <xref ref-type="fig" rid="pone.0182888.g004">Fig 4A</xref> and <xref ref-type="table" rid="pone.0182888.t001">Table 1</xref>. Conservatively, a <italic>COV</italic>
value of 17% is assumed in the following as the <italic>COV</italic> threshold
related to Hp geometry.</p><p>The <italic>cRC</italic> values were calculated for the spheres in the Rp phantom
according to Eq (<xref ref-type="disp-formula" rid="pone.0182888.e003">3</xref>) and
the calibration factors (<italic>S</italic>) derived from the two calibration
geometries. <italic>cRC</italic> and <italic>COV</italic> values are reported on the
vertical and lower horizontal axes of <xref ref-type="fig" rid="pone.0182888.g005">Fig 5</xref> (for Hp calibration factors) and <xref ref-type="fig" rid="pone.0182888.g006">Fig 6</xref> (for Js calibration factors), respectively,
with the corresponding <italic>EIs</italic> denoted on the upper horizontal axis.
The plots in A), B) and C) (indicated at the top of the graph) refer only to 5, 10
and 15 subsets in both <xref ref-type="fig" rid="pone.0182888.g005">Fig 5</xref> and
<xref ref-type="fig" rid="pone.0182888.g006">Fig 6</xref>, while for the sake of
brevity 20 and 30 subsets were not shown.</p><fig id="pone.0182888.g005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0182888.g005</object-id><label>Fig 5</label><caption><title>Concentration recovery coefficient for the Hp geometry.</title><p><italic>cRCs</italic> data versus <italic>COV</italic> and
<italic>EI</italic> for the 16 ml, 8 ml and 4 ml spheres considered in
the Rp phantom and using A) 5 subsets, B) 10 subsets and C) 15 subsets. The
continuous vertical lines refer to the 17% noise threshold.</p></caption><graphic xlink:href="pone.0182888.g005"/></fig><fig id="pone.0182888.g006" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0182888.g006</object-id><label>Fig 6</label><caption><title>Concentration recovery coefficient for the the Js geometry.</title><p><italic>cRCs</italic> data versus <italic>COV</italic> and
<italic>EI</italic> for the 16ml, 8ml and 4ml sphere considered in the
Rp phantom and relative to A) 5 subsets, B) 10 subsets and C) 15 subsets.
The continuous vertical lines refer to the 17% noise threshold.</p></caption><graphic xlink:href="pone.0182888.g006"/></fig><p>From a qualitative point of view, the trend of the data plot is the same for
calibration factors from both reference geometries. Moreover, the
<italic>cRC</italic> values in <xref ref-type="fig" rid="pone.0182888.g005">Fig
5</xref> are larger than the ones in <xref ref-type="fig" rid="pone.0182888.g006">Fig 6</xref>, showing that the calibration factors from
Hp are lower than that from Js for all <italic>EIs</italic> (Eq (<xref ref-type="disp-formula" rid="pone.0182888.e003">3</xref>) and <xref ref-type="fig" rid="pone.0182888.g003">Fig 3</xref>). Considering a
<italic>cRC</italic> value equal to 90% as a level of high reconstruction
accuracy [<xref rid="pone.0182888.ref017" ref-type="bibr">17</xref>], the data plot
of <xref ref-type="fig" rid="pone.0182888.g005">Fig 5</xref> reach this level, while
those reported in <xref ref-type="fig" rid="pone.0182888.g006">Fig 6</xref> do not
satisfy this requirement. In <xref ref-type="table" rid="pone.0182888.t003">Table
3</xref> are reported the data relative to <xref ref-type="fig" rid="pone.0182888.g005">Fig 5</xref>, referring to the 16 ml sphere.</p><table-wrap id="pone.0182888.t003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0182888.t003</object-id><label>Table 3</label><caption><title><italic>cRC</italic> values for the Rp phantom.</title><p>The data in the table corresponds to the points in <xref ref-type="fig" rid="pone.0182888.g005">Fig 5</xref> relative to the 16 ml sphere.</p></caption><alternatives><graphic id="pone.0182888.t003g" xlink:href="pone.0182888.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" colspan="2" rowspan="1">5-subsets</th><th align="center" colspan="2" rowspan="1">10-subsets</th><th align="center" colspan="2" rowspan="1">15-subsets</th></tr><tr><th align="center" rowspan="1" colspan="1">EI</th><th align="center" rowspan="1" colspan="1">16 ml</th><th align="center" rowspan="1" colspan="1">EI</th><th align="center" rowspan="1" colspan="1">16 ml</th><th align="center" rowspan="1" colspan="1">EI</th><th align="center" rowspan="1" colspan="1">16 ml</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">60,20%</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">91,20%</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">92,20%</td></tr><tr><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">86,30%</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">92,50%</td><td align="center" rowspan="1" colspan="1">30</td><td align="center" rowspan="1" colspan="1">93,60%</td></tr><tr><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">92,10%</td><td align="center" rowspan="1" colspan="1">30</td><td align="center" rowspan="1" colspan="1">93,90%</td><td align="center" rowspan="1" colspan="1">45</td><td align="center" rowspan="1" colspan="1">94,30%</td></tr><tr><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">93,90%</td><td align="center" rowspan="1" colspan="1">40</td><td align="center" rowspan="1" colspan="1">94,10%</td><td align="center" rowspan="1" colspan="1">60</td><td align="center" rowspan="1" colspan="1">94,40%</td></tr><tr><td align="center" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1">94,50%</td><td align="center" rowspan="1" colspan="1">50</td><td align="center" rowspan="1" colspan="1">94,00%</td><td align="center" rowspan="1" colspan="1">75</td><td align="center" rowspan="1" colspan="1">94,40%</td></tr><tr><td align="center" rowspan="1" colspan="1">30</td><td align="center" rowspan="1" colspan="1">94,60%</td><td align="center" rowspan="1" colspan="1">60</td><td align="center" rowspan="1" colspan="1">94,00%</td><td align="center" rowspan="1" colspan="1">90</td><td align="center" rowspan="1" colspan="1">94,30%</td></tr><tr><td align="center" rowspan="1" colspan="1">35</td><td align="center" rowspan="1" colspan="1">94,60%</td><td align="center" rowspan="1" colspan="1">70</td><td align="center" rowspan="1" colspan="1">94,00%</td><td align="center" rowspan="1" colspan="1">105</td><td align="center" rowspan="1" colspan="1">94,40%</td></tr><tr><td align="center" rowspan="1" colspan="1">50</td><td align="center" rowspan="1" colspan="1">94,60%</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">94,00%</td><td align="center" rowspan="1" colspan="1">150</td><td align="center" rowspan="1" colspan="1">94,50%</td></tr><tr><td align="center" rowspan="1" colspan="1">75</td><td align="center" rowspan="1" colspan="1">94,60%</td><td align="center" rowspan="1" colspan="1">150</td><td align="center" rowspan="1" colspan="1">94,10%</td><td align="center" rowspan="1" colspan="1">225</td><td align="center" rowspan="1" colspan="1">94,50%</td></tr><tr><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">94,70%</td><td align="center" rowspan="1" colspan="1">200</td><td align="center" rowspan="1" colspan="1">94,10%</td><td align="center" rowspan="1" colspan="1">300</td><td align="center" rowspan="1" colspan="1">94,50%</td></tr><tr><td align="center" rowspan="1" colspan="1">125</td><td align="center" rowspan="1" colspan="1">94,70%</td><td align="center" rowspan="1" colspan="1">250</td><td align="center" rowspan="1" colspan="1">94,10%</td><td align="center" rowspan="1" colspan="1">375</td><td align="center" rowspan="1" colspan="1">94,50%</td></tr><tr><td align="center" rowspan="1" colspan="1">150</td><td align="center" rowspan="1" colspan="1">94,70%</td><td align="center" rowspan="1" colspan="1">300</td><td align="center" rowspan="1" colspan="1">94,10%</td><td align="center" rowspan="1" colspan="1">450</td><td align="center" rowspan="1" colspan="1">94,30%</td></tr></tbody></table></alternatives></table-wrap><p>As shown, the <italic>cRC</italic> values at fixed <italic>EI</italic> are very
similar and the <italic>cRC</italic> convergence starts for <italic>EI</italic>
greater than or equal to 30 for all reconstructions considered and for the 16 ml
sphere. For the case of 20 and 30 subsets (plots not shown), the
<italic>cRC</italic> data show the same trend but the convergence is reached at
larger <italic>EI</italic>. Considering that for the Js geometry the minimum
<italic>COV</italic> values lies in the <italic>EI</italic> range between 50 and
150, the <italic>EI</italic> equal to 50 (i.e.
10<italic>s</italic>x5<italic>i</italic>) can be chosen as our working point
because is the best compromise between reducing the <italic>COV</italic> for both Hp
and Js geometries (<xref ref-type="table" rid="pone.0182888.t001">Table 1</xref> and
<xref ref-type="table" rid="pone.0182888.t002">Table 2</xref>) and, at the same
time, the <italic>cRC</italic> is in convergence. For this reason, the SPECT images
of the validation phantom were reconstructed using <italic>EI</italic> equal to 50,
and the percent difference between the injected and the reconstructed activity was
evaluated for the inner spherical insert. The difference was D<sub>1</sub> = -16.4%
(Hp geometry) and D<sub>2</sub> = -24.8% (Js geometry).</p></sec><sec sec-type="conclusions" id="sec009"><title>Discussion</title><p>Nowadays, in patients with unresectable or metastatic neuroendocrine tumors molecular
radiotherapy appears to be the most effective therapeutic strategy with limited
side-effects [<xref rid="pone.0182888.ref001" ref-type="bibr">1</xref>]. For this
reason, accurate quantitative imaging must be regarded as an essential integral part
of the whole dosimetry procedure. A pivotal element in a patient-specific dosimetry
approach using SPECT images is the accuracy of activity quantification inside tumor
regions and organs at risk. This is strictly related to the calibration method used
to convert SPECT data into activity, and to the SPECT reconstruction method used
(i.e. correction for attenuation, scatter, collimator response, activity recovery
and the number of 3D-OSEM algorithm updates). Our work focuses on the SPECT
calibration method and, in particular, on the optimization of the number of 3D-OSEM
updates when small volumes are taken into account for dosimetric evaluations.</p><p>A detailed procedure for SPECT calibration is currently missing, and there is no
doubt that an internationally agreed protocol would lead to further advances in this
area. At present, a phantom uniformly filled with a known amount of activity or hot
spheres in uniform background (as suggested by the MIRD pamphlet No. 23 [<xref rid="pone.0182888.ref017" ref-type="bibr">17</xref>]) are generally used in the
clinical practice to calibrate the imaging system.</p><p>The obtained results confirm and extend previous studies on gamma camera calibration
for quantitative SPECT imaging with <sup>177</sup>Lu. Recently, two studies strictly
related to this topic have been published [<xref rid="pone.0182888.ref025" ref-type="bibr">25</xref>,<xref rid="pone.0182888.ref029" ref-type="bibr">29</xref>], both testing different calibration
geometries. In particular, in the first [<xref rid="pone.0182888.ref025" ref-type="bibr">25</xref>] the quantitative accuracy measured by using
four calibration geometries (point source in air, sphere in air and in cold
background, and a hot cylindrical phantom) has been compared on two different SPECT
systems. The authors concluded that an accuracy to within approximately 10% can be
achieved in large phantoms uniformly filled with <sup>177</sup>Lu when the 208 keV
photopeak is used together with suitable correction algorithms to compensate the
major degrading effects. In another work [<xref rid="pone.0182888.ref029" ref-type="bibr">29</xref>], another four calibration geometries (hot
cylindrical phantom, hot bottles in air, hot spheres in hot background with two
concentration levels) have been considered. Interestingly, the authors concluded
that calibration factors obtained from all tomographic acquisitions agree within 7%
with each other and with the values obtained from planar scan. In the same study,
the authors obtained deviations below 5% for objects larger than 100 ml in a hot
background, and less than 18% for small objects, namely with a volume of about 9
ml.</p><p>Starting from these results, we have considered two calibration phantoms represented
by the Hp and Js geometries. The activity concentration considered in the Hp
geometry was representative of the typical activity concentration obtained in an
ideal patient (70 Kg in weight) administered with 7400 MBq of <sup>177</sup>Lu
activity. On the other hand, the activity concentration used in the Js geometry was
30.3 MBq/ml, a situation similar to that reported in [<xref rid="pone.0182888.ref025" ref-type="bibr">25</xref>]. Dead time correction was measured as
described in [<xref rid="pone.0182888.ref025" ref-type="bibr">25</xref>], and it was
found to be 0.5% and 1.2% for the Hp and Js geometries, respectively. As reported in
[<xref rid="pone.0182888.ref021" ref-type="bibr">21</xref>], the SPECT
calibration factor was not greatly influenced by the choice of OSEM updates. The
obtained calibration factor values for each reference geometry showed little
difference between them for the fairly narrow range of OSEM update combinations
considered.</p><p>One of the key issues in recovering activities in a clinical setting is the choice of
the number of OSEM updates, as noise in SPECT images may be a limiting factor. As
reported in MIRD pamphlet No. 26 [<xref rid="pone.0182888.ref018" ref-type="bibr">18</xref>], the optimal combination of subsets and iterations should be
obtained considering the identical activity recovery for tumor and critical organs
for the treatment (i.e. kidney in the case of neuroendocrine tumors), and those
authors assumed equal volumes for both tumor and kidney. As in the clinical case the
tumor volume is smaller than the kidney one, the present study focuses on small
volume lesions and investigates the <italic>COV</italic> and <italic>cRC</italic>
behaviors for Js and Rp phantoms (16 ml, 8 ml and 4 ml), respectively.</p><p>As for the <italic>COV</italic> values obtained, it is worth nothing that, contrary
to expectations, <italic>COV</italic> values for the Js (<xref ref-type="fig" rid="pone.0182888.g004">Fig 4B</xref>) tend to decrease with increasing
<italic>EI</italic> number up to 150 approximately, then <italic>COV</italic>
values increase linearly with <italic>EI</italic> number. The reason for this trend
is not yet wholly understood. However, there are several possible explanations for
this result. It can be conceivably hypothesized that VOI positioning is critical and
<italic>COV</italic> values may strongly depend on where the VOI is placed
(i.e., in the middle of the phantom in the case of Js). Another possible explanation
for this is that, on average, the voxel values within the sphere are gradually
moving toward their &#x0201c;true&#x0201d; value, especially those near the edge of the sphere.
After a number of <italic>EI</italic>, noise becomes dominant and
<italic>COV</italic> values increase linearly with <italic>EIs</italic>. Further
data collection would be needed to determine exactly how <italic>COV</italic> values
are affected by VOI positioning, <italic>EI</italic> number and other minor
effects.</p><p>Looking at the results shown in <xref ref-type="fig" rid="pone.0182888.g005">Fig
5</xref> and <xref ref-type="fig" rid="pone.0182888.g006">Fig 6</xref>, the
<italic>cRC</italic> convergence for all spheres starts at <italic>EI</italic>
values for which the noise level is below the 17%threshold. From the results
reported in <xref ref-type="table" rid="pone.0182888.t003">Table 3</xref>, an
<italic>EI</italic> value equal to 50 (i.e.
10<italic>s</italic>x5<italic>i</italic>) was chosen as the suitable OSEM
updates. With this choice, it results that the <italic>COV</italic> for both Hp and
Js geometries was below the established threshold. In fact, analyzing the data in
<xref ref-type="table" rid="pone.0182888.t001">Table 1</xref> and <xref ref-type="table" rid="pone.0182888.t002">Table 2</xref> the Hp
<italic>COV</italic> is 15.10%, while the Js <italic>COV</italic> is equal to
13.27%, representing the best compromise between the noise level for both large and
small volumes. Moreover, a resolution analysis (results not shown) has been
performed on a point like source filled with <sup>177</sup>Lu, and the full width at
half maximum (FWHM) has been evaluated as a function of 3D-OSEM updates. For
<italic>EI</italic> = 50, the FWHM reached a plateau, while for
<italic>EI</italic>&#x0003e;50 the FWHM was in convergence but the
<italic>COV</italic> threshold of 17% is exceeded for the case of Hp geometry.
Even if at an <italic>EI</italic> value equal to 30 the <italic>cRC</italic> plateau
is reached (<xref ref-type="fig" rid="pone.0182888.g005">Fig 5</xref> and <xref ref-type="fig" rid="pone.0182888.g006">Fig 6</xref>), the Js
<italic>COV</italic> is outside of the <italic>EI</italic> range in which its
minimum <italic>COV</italic> lies. In fact, the Js <italic>COV</italic> at
<italic>EI</italic> value equal to 50 is lower than the one at
<italic>EI</italic> value equal to 30 and, in the same time, the
<italic>cRC</italic> values are in convergence. For the same reason, an
<italic>EI</italic> value equal to 150 has been left out as the 17% threshold is
exceeded for all spheres (<xref ref-type="table" rid="pone.0182888.t001">Table
1</xref>). For the 20 and 30 subsets, the noise level reached in the
reconstructed images exceeds 17% (<xref ref-type="table" rid="pone.0182888.t001">Table 1</xref>). Moreover, for these last number of subsets the noise level for
1 and 2 iterations is lower than the established threshold (<xref ref-type="table" rid="pone.0182888.t001">Table 1</xref>), but the <italic>cRCs</italic> do not
reach a plateau for these combinations (data not shown in this study).</p><p>It is worth noting that our results are in agreement with previously published
findings. Ilan et colleagues [<xref rid="pone.0182888.ref009" ref-type="bibr">9</xref>] obtained similar quantitative accuracies in small objects, using the
same reference calibration geometry (Hp). Conversely, our results are higher than
those reported by Sanders [<xref rid="pone.0182888.ref021" ref-type="bibr">21</xref>] and Uribe [<xref rid="pone.0182888.ref029" ref-type="bibr">29</xref>].
Anyway, a straightforward comparison between our data and the data in [<xref rid="pone.0182888.ref021" ref-type="bibr">21</xref>,<xref rid="pone.0182888.ref029" ref-type="bibr">29</xref>] is not possible because the SPECT systems,
collimators, energy windows and software are different, affecting the efficiency and
resolutions of the SPECT systems.</p><p>Importantly, in the present study we used a phantom made of concentric spheres to
test the ability of the SPECT system to recover activity in challenging and
realistic conditions. In fact, the spherical shells have the potential to reproduce
a scenario of a high-uptake region surrounded by fainter circular area, which is
typical of a number of clinical situations (e.g. renal medulla). As it is not
possible to distinguish the spill-in and spill-out effect in this situation, the CT
based contour of the inner sphere was used to estimate the reconstructed activity.
Moreover, it is worth noting that the layer added by the outer sphere is about 4.8
mm, i.e. well below the system spatial resolution. As a consequence, the
reconstruction and detection capability of the SPECT system are pushed to the
limit.</p><p>Using the previously selected reconstruction parameters (<italic>EI</italic> = 50,
i.e. 10<italic>s</italic>x5<italic>i</italic>), the percent difference between the
reconstructed activity and the known activity inside the spherical tumor was found
to be -16.4% (using the calibration factor from Hp geometry) and -24.8% (using the
calibration factor from Js geometry) for the inner sphere of the insert. From these
results, the Hp geometry can be considered suitable to define the SPECT calibration.
Moreover, while this geometry does not include a correction for the partial volume
effect, important for dosimetry of small lesions, this last correction can be
accomplished by introducing the proper <italic>cRC</italic> as a function of the
volume under investigation.</p><p>Finally, we are aware that our research may have two limitations. Firstly, activity
measurements were performed using activity calibrators available in our department,
with an accuracy within &#x000b1;5%. It is likely that if activity is determined by a
National Metrology Institute (thereby providing activity measurements with errors
well below 2%), the quantitative accuracy in a clinical scenario can be greatly
improved. The second limitation concerns dead-time measurements. The low activity
concentration used for the assessment of dead-time through the dual source method is
likely to be a possible source of inaccuracy. Notwithstanding this, the measured
dead-time compares well with reported literature values [<xref rid="pone.0182888.ref030" ref-type="bibr">30</xref>]. Furthermore, minor uncertainties in
dead-time estimates are likely to have a negligible impact on the final
quantification analysis, given the relatively low activities used throughout the
study.</p><p>Ultimately, we are convinced that the present study provides considerable insight
into the accuracy achievable in quantitative SPECT imaging with <sup>177</sup>Lu in
a realistic clinical scenario. In particular our results provide further evidence
for suggesting the use of a large uniform phantom as reference geometry.</p></sec><sec sec-type="conclusions" id="sec010"><title>Conclusion</title><p>The use of a cylindrical homogeneous reference geometry, together with the gamma
camera acquisition parameters used for SPECT image acquisition, and optimization of
3D-OSEM updates has been proved suitable for <sup>177</sup>Lu SPECT activity
quantification related to small volumes.</p><p>The study deeply investigates the relationship between 3D-OSEM algorithm, object size
and <italic>COV</italic>. Considering the <italic>cRC</italic> together with these
variables can lead to a better compromise in terms of real activity recovery,
keeping the background noise as low as possible in the reconstructed SPECT images.
This can be achieved by means of the homogeneous cylindrical phantom, which does not
account for intrinsic corrections related to the partial volume effect with respect
to a calibration sphere. This last correction can be achieved by using a proper
<italic>cRC</italic> values calculated as a function of the volume under
investigation.</p></sec></body><back><ack><p>The authors are grateful to Paola Chiaramida and Elena Costantini (Product Clinical
Specialist in Molecular Imaging, GE Healthcare), Gil Kovalski (Functional Management
Principal Scientist &#x00026; Clinical apps Manager, GE Healthcare) and Avi Bar-Shalev
(Clinical Research and Development Senior Scientist Clinical Appplications, GE
Healthcare) for their support and valuable suggestions related to the SPECT system
and Xeleris workstation.</p><p>Moreover, the authors are grateful to Filippo Piccinici for his suggestions and
support during the revision phase of the manuscript.</p></ack><ref-list><title>References</title><ref id="pone.0182888.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Dash</surname><given-names>A</given-names></name>, <name><surname>Chakraborty</surname><given-names>S</given-names></name>, <name><surname>Pillai</surname><given-names>MR</given-names></name> and <name><surname>Knapp</surname><given-names>FF</given-names><suffix>Jr.</suffix></name>
<article-title>Peptide receptor radionuclide therapy: an
overview</article-title>. <source>Cancer Biother Radiopharm</source>.
<year>2015</year>
<month>3</month>; <volume>30</volume>(<issue>2</issue>):
<fpage>47</fpage>&#x02013;<lpage>71</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1089/cbr.2014.1741">10.1089/cbr.2014.1741</ext-link></comment>
<pub-id pub-id-type="pmid">25710506</pub-id></mixed-citation></ref><ref id="pone.0182888.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Molina Trinidad</surname><given-names>EM</given-names></name> and <name><surname>Salas Casas</surname><given-names>A</given-names></name>. <article-title>Somatostatine analogs, how biomarkers in the diagnostic
and treatment for cancer and others damages</article-title>. <source>Int J
Pharm Sci Rev Res</source>. <year>2014</year>
<season>Jul-Aug</season>
<day>6</day>; <volume>27</volume>(<issue>1</issue>):
<fpage>31</fpage>&#x02013;<lpage>46</lpage>.</mixed-citation></ref><ref id="pone.0182888.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Otte</surname><given-names>A</given-names></name>, <name><surname>Mueller-Brand</surname><given-names>J</given-names></name>, <name><surname>Dellas</surname><given-names>S</given-names></name>, <name><surname>Nitzsche</surname><given-names>EU</given-names></name>, <name><surname>Hermann</surname><given-names>R</given-names></name>, <name><surname>Maecke</surname><given-names>HR</given-names></name>. <article-title>Yttrium-90-labelled somatostatin-analogue for cancer
treatment</article-title>. <source>Lancet</source>. <year>1998</year>
<month>2</month>
<day>7</day>; <volume>351</volume>(<issue>9100</issue>):
<fpage>417</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="pmid">9482300</pub-id></mixed-citation></ref><ref id="pone.0182888.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Marincek</surname><given-names>N</given-names></name>, <name><surname>J&#x000f6;rg</surname><given-names>AC</given-names></name>, <name><surname>Brunner</surname><given-names>P</given-names></name>, <name><surname>Schindler</surname><given-names>C</given-names></name>, <name><surname>Koller</surname><given-names>MT</given-names></name>, <name><surname>Rochlitz</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>Somatostatin-based radiotherapy with
[90Y-DOTA]-TOC in neuroendocrine tumors: long-term outcome of phase I dose
escalation study</article-title>. <source>J Transl Med</source>.
<year>2013</year>
<month>1</month>
<day>15</day>; <fpage>11</fpage>&#x02013;<lpage>17</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1479-5876-11-11">10.1186/1479-5876-11-11</ext-link></comment><pub-id pub-id-type="pmid">23302473</pub-id></mixed-citation></ref><ref id="pone.0182888.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Paganelli</surname><given-names>G</given-names></name>, <name><surname>Sansovini</surname><given-names>M</given-names></name>, <name><surname>Ambrosetti</surname><given-names>A</given-names></name>, <name><surname>Severi</surname><given-names>S</given-names></name>, <name><surname>Monti</surname><given-names>M</given-names></name>, <name><surname>Scarpi</surname><given-names>E</given-names></name>, <etal>et al</etal>
<article-title>177 Lu-Dota-octreotate radionuclide
therapy of advanced gastrointestinal neuroendocrine tumors: results from a
phase II study</article-title>. <source>Eur J Nucl Med Mol Imaging</source>.
<year>2014</year>
<month>10</month>; <volume>41</volume>(<issue>10</issue>):
<fpage>1845</fpage>&#x02013;<lpage>1851</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00259-014-2735-5">10.1007/s00259-014-2735-5</ext-link></comment>
<pub-id pub-id-type="pmid">24615468</pub-id></mixed-citation></ref><ref id="pone.0182888.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Romer</surname><given-names>A</given-names></name>, <name><surname>Seiler</surname><given-names>D</given-names></name>, <name><surname>Marincek</surname><given-names>N</given-names></name>, <name><surname>Brunner</surname><given-names>P</given-names></name>, <name><surname>Koller</surname><given-names>MT</given-names></name>, <name><surname>Ng</surname><given-names>QKT</given-names></name>, <etal>et al</etal>
<article-title>Somatostatin-based radiopeptide
therapy with [<sup>177</sup>Lu-DOTA]-TOC versus [<sup>90</sup>Y-DOTA]-TOC in
neuroendocrine tumours</article-title>. <source>Eur J Nucl Med Mol
Imaging</source>. <year>2014</year>
<month>2</month>; <volume>41</volume>(<issue>2</issue>):
<fpage>214</fpage>&#x02013;<lpage>222</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00259-013-2559-8">10.1007/s00259-013-2559-8</ext-link></comment>
<pub-id pub-id-type="pmid">24085501</pub-id></mixed-citation></ref><ref id="pone.0182888.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Ezzidin</surname><given-names>S</given-names></name>, <name><surname>Khalaf</surname><given-names>F</given-names></name>, <name><surname>Vanezi</surname><given-names>M</given-names></name>, <name><surname>Haslerud</surname><given-names>T</given-names></name>, <name><surname>Mayer</surname><given-names>K</given-names></name>, <name><surname>Al Zreiqat</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Outcome of peptide receptor
radionuclide therapy with <sup>177</sup>Lu-octreotate in advanced grade &#x000bd;
pancreatic neuroendocrine tumours</article-title>. <source>Eur J Nucl Med
Mol Imaging</source>. <year>2014</year>
<month>5</month>; <volume>41</volume>(<issue>5</issue>):
<fpage>925</fpage>&#x02013;<lpage>933</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00259-013-2677-3">10.1007/s00259-013-2677-3</ext-link></comment>
<pub-id pub-id-type="pmid">24504504</pub-id></mixed-citation></ref><ref id="pone.0182888.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>van der Zwan</surname><given-names>W</given-names></name>, <name><surname>Bodei</surname><given-names>L</given-names></name>, <name><surname>Muelle-Brand</surname><given-names>J</given-names></name>, <name><surname>de Herder</surname><given-names>WW</given-names></name>, <name><surname>Kvols</surname><given-names>LK</given-names></name>, and <name><surname>Kwekkeboom</surname><given-names>DJ</given-names></name>. <article-title>GEPNETs update: Radionuclide therapy in neuroendocrine
tumors</article-title>. <source>Eur J Endocrinol</source>. <year>2015</year>
<month>1</month>; <volume>172</volume>(<issue>1</issue>):
<fpage>R1</fpage>&#x02013;<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1530/EJE-14-0488">10.1530/EJE-14-0488</ext-link></comment>
<pub-id pub-id-type="pmid">25117465</pub-id></mixed-citation></ref><ref id="pone.0182888.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Ilan</surname><given-names>E</given-names></name>, <name><surname>Sandstrom</surname><given-names>M</given-names></name>, <name><surname>Wassberg</surname><given-names>C</given-names></name>, <name><surname>Sundin</surname><given-names>A</given-names></name>, <name><surname>Garske-Roman</surname><given-names>U</given-names></name>, <name><surname>Eriksson</surname><given-names>B</given-names></name>, <etal>et al</etal>
<article-title>Dose response of pancreatic
neuroendocrine tumors treated with peptide receptor radionuclide therapy
using 177Lu-DOTATATE</article-title>. <source>J Nucl Med</source>.
<year>2015</year>
<month>2</month>; <volume>56</volume>(<issue>2</issue>):
<fpage>177</fpage>&#x02013;<lpage>82</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2967/jnumed.114.148437">10.2967/jnumed.114.148437</ext-link></comment>
<pub-id pub-id-type="pmid">25593115</pub-id></mixed-citation></ref><ref id="pone.0182888.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Bodei</surname><given-names>L</given-names></name>, <name><surname>Cremonesi</surname><given-names>M</given-names></name>, <name><surname>Grana</surname><given-names>CM</given-names></name>, <name><surname>Fazio</surname><given-names>N</given-names></name>, <name><surname>Iodice</surname><given-names>S</given-names></name>, <name><surname>Baio</surname><given-names>SM</given-names></name>, <etal>et al</etal>
<article-title>Peptide receptor radionuclide
therapy with 177Lu-Dotatate: the IEO phase I-II study</article-title>.
<source>Eur J Nucl Med Mol Imaging</source>. <year>2011</year>
<month>12</month>;
<volume>38</volume>(<issue>12</issue>):<fpage>2125</fpage>&#x02013;<lpage>35</lpage>.
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00259-011-1902-1">10.1007/s00259-011-1902-1</ext-link></comment>
<pub-id pub-id-type="pmid">21892623</pub-id></mixed-citation></ref><ref id="pone.0182888.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Sch&#x000e4;fer</surname><given-names>M</given-names></name>, <name><surname>Bauder-W&#x000fc;st</surname><given-names>U^G</given-names></name>, <name><surname>Afshar-Oromieh</surname><given-names>A</given-names></name>, <name><surname>Kratochwil</surname><given-names>C</given-names></name>, <name><surname>Mier</surname><given-names>W</given-names></name>, <name><surname>Haberkorn</surname><given-names>U</given-names></name>, <etal>et al</etal>
<article-title>Preclinical evaluation of a
tailor-made DOTA-conjugated PSMA inhibitor with optimized linker moiety for
imaging and endoradiotherapy of prostate cancer</article-title>. <source>J
Nucl Med</source>. <year>2015</year>
<month>6</month>; <volume>56</volume>(<issue>6</issue>):
<fpage>914</fpage>&#x02013;<lpage>20</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2967/jnumed.114.147413">10.2967/jnumed.114.147413</ext-link></comment>
<pub-id pub-id-type="pmid">25883127</pub-id></mixed-citation></ref><ref id="pone.0182888.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Afshar-Oromieh</surname><given-names>A</given-names></name>, <name><surname>Kratochwil</surname><given-names>C</given-names></name>, <name><surname>Benesova</surname><given-names>M</given-names></name>, <name><surname>Eder</surname><given-names>M</given-names></name>, <name><surname>Neels</surname><given-names>OC</given-names></name>, <name><surname>Eisenhut</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>The novel theranostic PSMA ligand
PSMA-617 in the diagnosis of prostate cancer by PET/CT: biodistribution in
humans, radiation dosimetry and first evaluation of tumor
lesions</article-title>. <source>J Nucl Med</source>. <year>2015</year>
<month>11</month>; <volume>56</volume> (<issue>11</issue>):
<fpage>1697</fpage>&#x02013;<lpage>705</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2967/jnumed.115.161299">10.2967/jnumed.115.161299</ext-link></comment>
<pub-id pub-id-type="pmid">26294298</pub-id></mixed-citation></ref><ref id="pone.0182888.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Kratochwil</surname><given-names>C</given-names></name>, <name><surname>Giesel</surname><given-names>FL</given-names></name>, <name><surname>Eder</surname><given-names>M</given-names></name>, <name><surname>Afshar-Oromieh</surname><given-names>A</given-names></name>, <name><surname>Bene&#x00161;ov&#x000e1;</surname><given-names>M</given-names></name>, <name><surname>Mier</surname><given-names>W</given-names></name>, <etal>et al</etal>
<article-title>[177Lu]Lutetium-labelled PSMA
ligand-induced remission in a patient with metastatic prostate
cancer</article-title>. <source>Eur J Nucl Med Mol Imaging</source>.
<year>2015</year>
<month>5</month>; <volume>42</volume> (<issue>6</issue>):
<fpage>987</fpage>&#x02013;<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00259-014-2978-1">10.1007/s00259-014-2978-1</ext-link></comment>
<pub-id pub-id-type="pmid">25573634</pub-id></mixed-citation></ref><ref id="pone.0182888.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Pillai</surname><given-names>MRA</given-names></name>, <name><surname>Knapp</surname><given-names>FF</given-names></name>. <article-title>Lu-177 labeled therapeutics: 177Lu-PSMA is set to
redefine prostate cancer treatment</article-title>. <source>Curr
Radiopharm</source>, <year>2016</year>:
<volume>9</volume>(<issue>1</issue>): <fpage>6</fpage>&#x02013;<lpage>7</lpage>.
<pub-id pub-id-type="pmid">26655262</pub-id></mixed-citation></ref><ref id="pone.0182888.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Ritt</surname><given-names>P</given-names></name>, <name><surname>Vija</surname><given-names>H</given-names></name>, <name><surname>Hornegger</surname><given-names>J</given-names></name>, and <name><surname>Torsten</surname><given-names>Kuwert</given-names></name>. <article-title>Absolute quantification in SPECT</article-title>.
<source>Eur J Nucl Med Imaging</source>. <year>2011</year>
<month>5</month>; <volume>38</volume>
<issue>Suppl 1</issue>:<fpage>S69</fpage>&#x02013;<lpage>77</lpage>. <comment>doi:
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00259-011-1770-8">10.1007/s00259-011-1770-8</ext-link></comment>
<pub-id pub-id-type="pmid">21484383</pub-id></mixed-citation></ref><ref id="pone.0182888.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Sgouros</surname><given-names>G</given-names></name> and <name><surname>Hobbs</surname><given-names>RF</given-names></name>. <article-title>Dosimetry for radiopharmaceutical
therapy</article-title>. <source>Semin Nucl Med</source>. <year>2014</year>
<month>5</month>; <volume>44</volume>(<issue>3</issue>):
<fpage>172</fpage>&#x02013;<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1053/j.semnuclmed.2014.03.007">10.1053/j.semnuclmed.2014.03.007</ext-link></comment>
<pub-id pub-id-type="pmid">24832581</pub-id></mixed-citation></ref><ref id="pone.0182888.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Dewaraja</surname><given-names>YK</given-names></name>, <name><surname>Frey</surname><given-names>EC</given-names></name>, <name><surname>Sgouros</surname><given-names>G</given-names></name>, <name><surname>Brill</surname><given-names>AB</given-names></name>, <name><surname>Roberson</surname><given-names>P</given-names></name>, <name><surname>Zanzonico</surname><given-names>PB</given-names></name>, <name><surname>Ljungberg</surname><given-names>M</given-names></name>. <article-title>MIRD Pamphlet No. 23: Quantitative SPECT for
Patient-Specific 3-Dimensional Dosimetry in Internal Radionuclide
Therapy</article-title>. <source>J Nucl Med</source>. <year>2012</year>
<month>8</month>; <volume>53</volume>(<issue>8</issue>):
<fpage>1310</fpage>&#x02013;<lpage>25</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2967/jnumed.111.100123">10.2967/jnumed.111.100123</ext-link></comment>
<pub-id pub-id-type="pmid">22743252</pub-id></mixed-citation></ref><ref id="pone.0182888.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Ljungberg</surname><given-names>M</given-names></name>, <name><surname>Konijnenberg</surname><given-names>MW</given-names></name>, <name><surname>Eckerman</surname><given-names>KF</given-names></name>, <name><surname>Dewaraja</surname><given-names>YK</given-names></name>, <name><surname>Sj&#x000f6;green-Gleisner</surname><given-names>K</given-names></name>. <article-title>MIRD Pamphlet No. 26: Joint EANM/MIRD Guidelines for
Quantitative 177Lu SPECT Applied for Dosimetry of Radiopharmaceutical
Therapy</article-title>. <source>J Nucl Med.</source>
<year>2016</year>
<month>1</month>; <volume>57</volume>(<issue>1</issue>):
<fpage>151</fpage>&#x02013;<lpage>62</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2967/jnumed.115.159012">10.2967/jnumed.115.159012</ext-link></comment>
<pub-id pub-id-type="pmid">26471692</pub-id></mixed-citation></ref><ref id="pone.0182888.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Beauregard</surname><given-names>JM</given-names></name>, <name><surname>Hofman</surname><given-names>MS</given-names></name>, <name><surname>Pereira</surname><given-names>JM</given-names></name>, <name><surname>EU</surname><given-names>P</given-names></name>, and <name><surname>Hicks</surname><given-names>RJ</given-names></name>. <article-title>Quantitative 177Lu SPECT (QSPECT) imaging using a
commercially available SPECT/CT system</article-title>. <source>Cancer
Imaning</source>
<year>2011</year>
<month>6</month>
<day>15</day>; <volume>11</volume>: <fpage>56</fpage>&#x02013;<lpage>66</lpage>.
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1102/1470-7330.2011.0012">10.1102/1470-7330.2011.0012</ext-link></comment>
<pub-id pub-id-type="pmid">21684829</pub-id></mixed-citation></ref><ref id="pone.0182888.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>de Nijs</surname><given-names>R</given-names></name>, <name><surname>Lagerburg</surname><given-names>V</given-names></name>, <name><surname>Klausen</surname><given-names>TL</given-names></name>, and <name><surname>Holm</surname><given-names>S</given-names></name>. <article-title>Improving quantitative dosimetry in 177Lu_DOTATATE SPECT
by energy window-based scatter corrections</article-title>. <source>Nucl Med
Comm</source>
<year>2014</year>
<month>5</month>; <volume>35</volume>(<issue>5</issue>):
<fpage>522</fpage>&#x02013;<lpage>33</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/MNM.0000000000000079">10.1097/MNM.0000000000000079</ext-link></comment>
<pub-id pub-id-type="pmid">24525900</pub-id></mixed-citation></ref><ref id="pone.0182888.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Sanders</surname><given-names>JC</given-names></name>, <name><surname>Kuwert</surname><given-names>T</given-names></name>, <name><surname>Hornegger</surname><given-names>J</given-names></name>, and <name><surname>Ritt</surname><given-names>P</given-names></name>. <article-title>Quantitative SPECT/CT imaging of 177Lu with in vivo
validation in patients undergoing peptide receptor radionuclide
therapy</article-title>. <source>Mol Immaging Biol</source>.
<year>2015</year>
<month>8</month>; <volume>17</volume>(<issue>4</issue>):
<fpage>585</fpage>&#x02013;<lpage>93</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s11307-014-0806-4">10.1007/s11307-014-0806-4</ext-link></comment>
<pub-id pub-id-type="pmid">25475521</pub-id></mixed-citation></ref><ref id="pone.0182888.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Shcherbinin</surname><given-names>S</given-names></name>, <name><surname>Piwowarska-Bilska</surname><given-names>H</given-names></name>, <name><surname>Celler</surname><given-names>A</given-names></name>, <name><surname>Birkenfeld</surname><given-names>B</given-names></name>. <article-title>Quantitative SPECT/CT reconstruction for
<sup>177</sup>Lu and <sup>177</sup>Lu/<sup>90</sup>Y targeted radionuclide
therapies</article-title>. <source>Phys Med Biol</source>.
<year>2012</year>;
<volume>57</volume>(<issue>18</issue>):<fpage>5733</fpage>&#x02013;<lpage>47</lpage>.
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1088/0031-9155/57/18/5733">10.1088/0031-9155/57/18/5733</ext-link></comment>
<pub-id pub-id-type="pmid">22948135</pub-id></mixed-citation></ref><ref id="pone.0182888.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Hippel&#x000e4;inen</surname><given-names>S</given-names></name>, <name><surname>Tenhunen</surname><given-names>M</given-names></name>, <name><surname>M&#x000e4;enp&#x000e4;&#x000e4;</surname><given-names>H</given-names></name>, and <name><surname>Sohlberg</surname><given-names>A</given-names></name>. <article-title>Quantitative accuracy of 177Lu SPECT reconstruction
using different compensation methods: phantom and patient
studies</article-title>. <source>EJNMMI Res</source>. <year>2016</year>
<month>12</month>; <volume>6</volume>(<issue>1</issue>): <fpage>16</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/s13550-016-0172-0">10.1186/s13550-016-0172-0</ext-link></comment>
<pub-id pub-id-type="pmid">26887986</pub-id></mixed-citation></ref><ref id="pone.0182888.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Zeintl</surname><given-names>J</given-names></name>, <name><surname>Vija</surname><given-names>AH</given-names></name>, <name><surname>Yahil</surname><given-names>A</given-names></name>, <name><surname>Hornegger</surname><given-names>J</given-names></name>, <name><surname>Kuwert</surname><given-names>T</given-names></name>. <article-title>Quantitative accuracy of clinical <sup>99m</sup>Tc
SPECT/CT using ordered-subset expectation maximization with 3-dimensional
resolution recovery, attenuation, and scatter correction</article-title>.
<source>J Nucl Med</source>. <year>2010</year>
<month>6</month>; <volume>51</volume>(<issue>6</issue>):
<fpage>921</fpage>&#x02013;<lpage>28</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2967/jnumed.109.071571">10.2967/jnumed.109.071571</ext-link></comment>
<pub-id pub-id-type="pmid">20484423</pub-id></mixed-citation></ref><ref id="pone.0182888.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>D&#x02019;Arienzo</surname><given-names>M</given-names></name>, <name><surname>Cazzato</surname><given-names>M</given-names></name>, <name><surname>Cozzella</surname><given-names>ML</given-names></name>, <name><surname>Cox</surname><given-names>M</given-names></name>, <name><surname>D&#x02019;Andrea</surname><given-names>M</given-names></name>, <name><surname>Fazio</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Gamma camera calibration and
validation for quantitative SPECT imaging with 177 Lu</article-title>.
<source>Appl Radiat Isot</source>. <year>2016</year>
<month>6</month>;<volume>112</volume>:<fpage>156</fpage>&#x02013;<lpage>64</lpage>.
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.apradiso.2016.03.007">10.1016/j.apradiso.2016.03.007</ext-link></comment>
<pub-id pub-id-type="pmid">27064195</pub-id></mixed-citation></ref><ref id="pone.0182888.ref026"><label>26</label><mixed-citation publication-type="book"><name><surname>Cherry</surname><given-names>SR</given-names></name>, <name><surname>Sorenson</surname><given-names>JA</given-names></name>, <name><surname>Phelps</surname><given-names>ME</given-names></name>. <source>Physics in Nuclear Medicine</source>. <edition>4<sup>th</sup>
ed</edition>
<publisher-name>Saunders/Elsevier</publisher-name>,
<publisher-loc>Philadelphia</publisher-loc>,
<year>2012</year>.</mixed-citation></ref><ref id="pone.0182888.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Hudson</surname><given-names>HM</given-names></name>, <name><surname>Larkin</surname><given-names>RS</given-names></name>. <article-title>Accelerated image reconstruction using ordered subsets
of projection data</article-title>. <source>IEEE Trans Med Imaging</source>.
<year>1994</year>;<volume>13</volume>(<issue>4</issue>):<fpage>601</fpage>&#x02013;<lpage>9</lpage>.
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1109/42.363108">10.1109/42.363108</ext-link></comment>
<pub-id pub-id-type="pmid">18218538</pub-id></mixed-citation></ref><ref id="pone.0182888.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Gnesin</surname><given-names>S</given-names></name>, <name><surname>Leite Ferreira</surname><given-names>P</given-names></name>, <name><surname>Malterre</surname><given-names>J</given-names></name>, <name><surname>Laub</surname><given-names>P</given-names></name>, <name><surname>O.Prior</surname><given-names>J</given-names></name> and <name><surname>Verdun</surname><given-names>FR</given-names></name>. <article-title>Phantom validation of Tc-99m absolute quantification in
a SPECT/CT commercial device</article-title>. <source>Computational and
Mathematical Methods in Medicine</source>, vol. <volume>2016</volume>;
<year>2016</year>:<fpage>4360371</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1155/2016/4360371">10.1155/2016/4360371</ext-link></comment>
<pub-id pub-id-type="pmid">28096891</pub-id></mixed-citation></ref><ref id="pone.0182888.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Uribe</surname><given-names>CF</given-names></name>, <name><surname>Esquinas</surname><given-names>PL</given-names></name>, <name><surname>Tanguay</surname><given-names>J</given-names></name>, <name><surname>Gonzales</surname><given-names>M</given-names></name>, <name><surname>Gaudin</surname><given-names>E</given-names></name>, <name><surname>Beuregard</surname><given-names>JM</given-names></name>, <name><surname>Celler</surname><given-names>A</given-names></name>. <article-title>Accuracy of 177Lu activity quantification in SPECT
imaging: a phantom study</article-title>. <source>EJNMMI</source>
<year>2017</year>
<month>12</month>; <volume>4</volume>(<issue>1</issue>): <fpage>2</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/s40658-016-0170-3">10.1186/s40658-016-0170-3</ext-link></comment>
<pub-id pub-id-type="pmid">28063068</pub-id></mixed-citation></ref><ref id="pone.0182888.ref030"><label>30</label><mixed-citation publication-type="book"><name><surname>Zeng</surname><given-names>GL</given-names></name>, <name><surname>Galt</surname><given-names>JR</given-names></name>, <name><surname>Wernick</surname><given-names>MN</given-names></name>, <name><surname>Mintzer</surname><given-names>RA</given-names></name> and <name><surname>Aarsvold</surname><given-names>JN</given-names></name>. <chapter-title>Single-Photon Emission Computed
Tomography</chapter-title>
<source>In: Emission Tomography: The
Fundamentals of PET and SPECT</source>. <publisher-name>Elsevier
Inc.</publisher-name>; <year>2004</year> pp.
<fpage>127</fpage>&#x02013;<lpage>152</lpage>.</mixed-citation></ref></ref-list></back></article>